Still unmet problems with low molecular weight heparin prophylaxis of venous thromboembolism. An Italian survey

Background: a survey was launched to assess the challenges that Italian patients and physicians face with home prophylaxis using low-molecular-weight heparin (LMWH), promoted by the "Arianna Anticoagulazione" Foundation, Bologna, Italy.Methods: conducted between March and October 2024, the survey targeted readers of the "anticoagulazione.it" website, distributed through a newsletter and social media. There were two different surveys, one addressed to patients\caregivers and the other to physicians.Results: the professional survey revealed significant uncertainties about managing chronic patients, with over half of physicians identifying them as a "gray area." A third of clinicians were unsure about the duration and necessity of home prophylaxis for acute patients. Arbitrary suspension of treatment was reported by a significantly lower proportion of patients\caregivers than professionals (4% vs 38%; p<0.0001).Conclusions: home prophylaxis presents challenges, especially for chronic patients, acute patients treated at home, and those with specific conditions (e.g., renal insufficiency or extreme body weight). The lack of clear guidelines and the widespread use of LMWH outside standard recommendations highlights the need for large-scale clinical trials to address these issues. Discrepancy in compliance reported by patients\caregivers and clinicians underline the need for improved professional-patient communication.

• Publication year

  2025

• Venue

  Bleeding Thrombosis and Vascular Biology

• Publication date

  2025-10-03

• Fields of study

  Not labeled

• Identifiers
  DOI 10.4081/btvb.2025.177
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Anticoagulants for thrombosis prophylaxis in acutely ill patients admitted to hospital: systematic review and network meta-analysis

  2022cited by this paper
• Association Between Missed Doses of Chemoprophylaxis and VTE Incidence in a Statewide Colectomy Cohort.

  2020cited by this paper
• Post-Discharge Prophylaxis With Rivaroxaban Reduces Fatal and Major Thromboembolic Events in Medically Ill Patients

  2020cited by this paper
• American Society of Hematology 2019 guidelines for management of venous thromboembolism: prevention of venous thromboembolism in surgical hospitalized patients.

  2019cited by this paper
• Venous Thromboembolism Prophylaxis and Risk in the Inpatient and Outpatient Continuum of Care Among Hospitalized Acutely Ill Patients in the US: A Retrospective Analysis

  2018cited by this paper
• American Society of Hematology 2018 guidelines for management of venous thromboembolism: prophylaxis for hospitalized and nonhospitalized medical patients.

  2018cited by this paper
• Missed Doses of Venous Thromboembolism (VTE) Prophylaxis at Community Hospitals: Cause for Alarm

  2017cited by this paper
• The epidemiology of venous thromboembolism

  2016cited by this paper
• Correlation of missed doses of enoxaparin with increased incidence of deep vein thrombosis in trauma and general surgery patients.

  2014cited by this paper
• Patterns of Non-Administration of Ordered Doses of Venous Thromboembolism Prophylaxis: Implications for Novel Intervention Strategies

  2013cited by this paper
• Prevention of VTE in nonsurgical patients: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.

  2012cited by this paper
• Predictive and associative models to identify hospitalized medical patients at risk for VTE.

  2011cited by this paper
• Post-discharge compliance to venous thromboembolism prophylaxis in high-risk orthopaedic surgery

  2011cited by this paper
• Nonadherence in Outpatient Thrombosis Prophylaxis with Low Molecular Weight Heparins after Major Orthopaedic Surgery

  2010cited by this paper
• Adherence to pharmacological thromboprophylaxis orders in hospitalized patients.

  2010cited by this paper
• A risk assessment model for the identification of hospitalized medical patients at risk for venous thromboembolism: the Padua Prediction Score

  2010cited by this paper
• Are hospitals delivering appropriate VTE prevention? The venous thromboembolism study to assess the rate of thromboprophylaxis (VTE start)

  2009influential reference
• Physician compliance with advanced electronic alerts for preventing venous thromboembolism among hospitalized medical patients

  2009cited by this paper
• Duration and magnitude of the postoperative risk of venous thromboembolism in middle aged women: prospective cohort study

  2009cited by this paper
• The epidemiology of venous thromboembolism in the community.

  2008cited by this paper
• Thromboprophylaxis rates in US medical centers: success or failure?

  2007cited by this paper
• Promoting effective transitions of care at hospital discharge: a review of key issues for hospitalists.

  2007cited by this paper
• Deficits in communication and information transfer between hospital-based and primary care physicians: implications for patient safety and continuity of care.

  2007cited by this paper
• Venous thromboembolism in the outpatient setting.

  2007cited by this paper
• Compliance with Low Molecular Weight Heparin in abulatory orthopedic patients.

  2006cited by this paper
• Patient compliance with outpatient prophylaxis: an observational study.

  2005cited by this paper
• The Epidemiology of Venous Thromboembolism

  2003cited by this paper
• DVT Prevention: What Is Happening in the “Real World”?

  2003cited by this paper
• The Epidemiology of Venous Thromboembolism in the Community

  2001cited by this paper
• A computerized reminder system to increase the use of preventive care for hospitalized patients.

  2001cited by this paper
• Incidence of Venous Thromboembolism: A Community-based Study in Western France

  2000cited by this paper
• Comparison of enoxaparin and warfarin for the prevention of venous thromboembolic disease after total hip arthroplasty. Evaluation during hospitalization and three months after discharge.

  1999cited by this paper
• Incidence and time course of thromboembolic outcomes following total hip or knee arthroplasty.

  1998cited by this paper

• No citing papers are available for this paper.